NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Ruihui,Xie

第一单位： Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, P. R. China.

作者： Ruihui,Xie ^[1] ; Liang,Cheng ^[2] ; Ming,Huang ^[1] ; Lin,Huang ^[2] ; Ziyue,Chen ^[1] ; Qiang,Zhang ^[2] ; Hong,Li ^[2] ; Junlin,Lu ^[3] ; Hongjin,Wang ^[2] ; Qianghua,Zhou ^[4] ; Jian,Huang ^[1] ; Xu,Chen ^[2] ; Tianxin,Lin ^[1]

作者单位： Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, P. R. China. ^[1] Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, P. R. China. ^[2] Department of Pediatric Surgery, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, P. R. China. ^[3] Jingke BioMed Laboratory, Guangzhou Jingke Biotech Group, Guangzhou, P. R. China. ^[4] Guangdong Provincial Clinical Research Center for Urological Diseases, Guangzhou, Guangdong, P. R. China. ^[5]